These observations support the hypothesis that tyrosine kinase inhibitor monotherapies could be ineffective against MM, in line with the data from clinical studies exploring, for example, the effects of EGFR inhibition in MM patients [13]. Here, EGFR is linked to Miyoshi myopathy.